Section Arrow
HAE.NYSE
- Haemonetics Corp
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 120.16
0 (0.00%)
Bid
97
Ask
192.2
High 120.16 
Low 119 
Volume 20.85K 
Regular Hours (Closed)
Last
 120.16
-0.21 (-0.17%)
Day High 
122.34 
Prev. Close
120.37 
1-M High
132 
Volume 
382.95K 
Bid
97
Ask
192.2
Day Low
119.68 
Open
120.37 
1-M Low
115.4924 
Market Cap 
5.48B 
Currency 美元 
P/E 53.26 
%Yield -- 
10-SMA 121.22 
20-SMA 120.98 
50-SMA 114.82 
52-W High 132 
52-W Low 51 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
2.26/5.68
Enterprise Value
6.70B
Balance Sheet
Book Value Per Share
19.73
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
1.33B
Operating Revenue Per Share
27.21
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.